France fines J&J 25 mln euros over painkiller patch

PARIS (Reuters) - France's competition authority fined U.S. healthcare group Johnson & Johnson 25 million euros ($29.62 million) on Wednesday after it found the company had deliberately slowed market access to generic copies of its painkiller Durogesic.